More evidence supports vismodegib therapy for advanced periocular basal cell carcinoma
- Posted on: Nov 27 2019
- Leave a response
This retrospective case series evaluated the effectiveness of the hedgehog pathway inhibitor vismodegib for advanced periocular basal cell carcinoma (BCC).
Source: AAO
Posted in: Uncategorized